Advances and prospects in neurocritical care in 2022 and 2023
Chen Yuqing
Wang Shuya
Zhang Linlin
Zhou Jianxin
Abstract：In the treatment of ischemic stroke,the extended time window for thrombectomy and the emergence of novel thrombolytic agents and strategies have brought greater hope for patient recovery.Minimally invasive hematoma evacuation and goal-directed bundled management have shown clinical benefits in treating cerebral hemorrhage.Decompressive craniectomy for severe traumatic brain injury has also obtained high-quality evidence support.In the critical care of neurocritical patients,abundant high-quality studies have emerged in the areas including multimodal neuromonitoring,airway management and respiratory therapy,and antiepileptic treatment.In 2022 and 2023,the guidelines for aneurysmal subarachnoid hemorrhage and intracerebral hemorrhage have been updated for the first time in years.Chinese expert consensuses have also been formulated to guide analgesia,sedation,and nutrition for neurocritical patients.In summary,encouraging progress has been achieved in the field of neurocritical care.However,more high-quality studies are still warranted in the future to inform the precise and personalized medicine.
Keywords：Neurocritical careIntracerebral hemorrhageCerebral infarctionTraumatic brain injurySubarachnoid hemorrhageCardiac arrestEndovascular therapyDecompressive craniectomy
Publication Date：2024-01-10
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：8( 30-37 )